Evaluation of a high-sensitivity SARS-CoV-2 antigen test on the fully automated light-initiated chemiluminescent immunoassay platform.
Minghang YuDanying ChenXiaomeng TangYuanyuan ZhangPu LiangYang XiongRui LiRui SongXiaoyou ChenXuesen ZhaoXi WangRonghua JinPublished in: Clinical chemistry and laboratory medicine (2023)
system provides an exceptionally high-sensitivity and fully automated platform for the detection of the SARS-CoV-2 antigen in nasal swabs. The assay may have high potential use for large-scale population screening and surveillance of COVID-19 as an alternative to the rRT-PCR test.